FLEXION THERAPEUTICS INC's ticker is and the CUSIP is 33938JAB2. A total of 23 filers reported holding FLEXION THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $9,710,000 | -0.6% | 10,961,000 | +1.2% | 0.18% | -5.3% |
Q2 2021 | $9,765,000 | +5.0% | 10,833,000 | +3.9% | 0.19% | -5.0% |
Q1 2021 | $9,301,000 | +3.7% | 10,429,000 | +4.0% | 0.20% | +4.7% |
Q4 2020 | $8,966,000 | -34.5% | 10,030,000 | -42.2% | 0.19% | -36.8% |
Q3 2020 | $13,689,000 | -10.2% | 17,343,000 | -3.2% | 0.30% | -15.4% |
Q2 2020 | $15,239,000 | +7.4% | 17,910,000 | -1.3% | 0.36% | +15.5% |
Q1 2020 | $14,194,000 | -9.2% | 18,148,000 | +24.0% | 0.31% | +2.0% |
Q4 2019 | $15,629,000 | -8.4% | 14,636,000 | -22.6% | 0.30% | -5.3% |
Q3 2019 | $17,070,000 | +11.2% | 18,907,000 | +7.6% | 0.32% | +7.7% |
Q2 2019 | $15,353,000 | -4.0% | 17,571,000 | -3.8% | 0.30% | -15.9% |
Q1 2019 | $16,001,000 | +43.7% | 18,274,000 | +35.2% | 0.35% | +31.2% |
Q4 2018 | $11,135,000 | -24.0% | 13,513,000 | -6.8% | 0.27% | -10.9% |
Q3 2018 | $14,655,000 | -0.1% | 14,499,000 | +21.3% | 0.30% | -2.3% |
Q2 2018 | $14,665,000 | – | 11,953,000 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birch Grove Capital LP | 20,150,000 | $17,845,000 | 8.41% |
PenderFund Capital Management Ltd. | 9,000,000 | $10,366,000 | 2.71% |
ZAZOVE ASSOCIATES LLC | 15,688,000 | $14,022,000 | 1.23% |
SILVERBACK ASSET MANAGEMENT LLC | 9,210,000 | $8,254,000 | 1.21% |
ABSOLUTE INVESTMENT ADVISERS, LLC | 3,550,000 | $3,164,000 | 1.11% |
Opti Capital Management, LP | 13,158,000 | $11,742,000 | 1.10% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 35,558,000 | $31,736,000 | 0.84% |
ADVENT CAPITAL MANAGEMENT /DE/ | 10,961,000 | $9,710,000 | 0.18% |
SSI INVESTMENT MANAGEMENT LLC | 3,250,000 | $2,877,000 | 0.17% |
Advisor Resource Council | 582,000 | $512,000 | 0.16% |